Jakob Dupont

Insider Reports History

Location
Redwood City, CA
Signature
/s/ William P. Quinn, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jakob Dupont:

Company Role Class Num Shares Value Price $ Report Date Ownership
Atara Biotherapeutics, Inc. EVP, Head of R&D Common Stock 290,794 $113,119 $0.3890 02 Mar 2023 Direct
Pyxis Oncology, Inc. Director Stock Option (Right to Buy) 36,979 $36,239 $0.9800 31 Mar 2025 Direct
Atara Biotherapeutics, Inc. EVP, Head of R&D Employee Stock Option (Right to Buy) 317,987 01 Mar 2023 Direct
Bolt Biotherapeutics, Inc. Director Stock Option (Right to Buy) 1,100 27 May 2025 Direct
Apexigen, Inc. Director Stock Option (right to buy) 0 23 Aug 2023 Direct
Bolt Biotherapeutics, Inc. Director Director Stock Option (Right to Buy) 0 12 Dec 2025 Direct

Insider Reports Filed by Jakob Dupont

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BOLT Bolt Biotherapeutics, Inc. 12 Dec 2025 8 $0 4 Director 16 Dec 2025, 17:15
BOLT Bolt Biotherapeutics, Inc. 27 May 2025 1 $0 4 Director 02 Jul 2025, 16:05
BOLT Bolt Biotherapeutics, Inc. 01 May 2025 1 $0 4 Director 05 May 2025, 21:28
PYXS Pyxis Oncology, Inc. 31 Mar 2025 1 +$36,239 4 Director 02 Apr 2025, 09:00
BOLT Bolt Biotherapeutics, Inc. 03 Sep 2024 2 $0 4 Director 06 Sep 2024, 12:19
BOLT Bolt Biotherapeutics, Inc. 03 Sep 2024 0 $0 3 Director 06 Sep 2024, 12:18
PYXS Pyxis Oncology, Inc. 26 Mar 2024 1 $0 4 Director 28 Mar 2024, 16:32
PYXS Pyxis Oncology, Inc. 22 Sep 2023 1 $0 4 Director 26 Sep 2023, 19:04
/report/000120919123047446-dupont-jakob-2023-08-23 Apexigen, Inc. 23 Aug 2023 3 $0 4 Director 25 Aug 2023, 19:29
PYXS Pyxis Oncology, Inc. 23 Aug 2023 3 $0 4 Director 25 Aug 2023, 17:30
PYXS Pyxis Oncology, Inc. 23 Aug 2023 0 $0 3 Director 25 Aug 2023, 17:28
ATRA Atara Biotherapeutics, Inc. 02 Mar 2023 1 -$18,403 4 EVP, Head of R&D 06 Mar 2023, 17:46
ATRA Atara Biotherapeutics, Inc. 01 Mar 2023 2 $0 4 EVP, Head of R&D 03 Mar 2023, 16:15
ATRA Atara Biotherapeutics, Inc. 16 Nov 2022 2 -$19,497 4 EVP, Head of R&D 18 Nov 2022, 19:13
/report/000120919122051935-dupont-jakob-2022-09-29 Apexigen, Inc. 29 Sep 2022 1 $0 4 Director 03 Oct 2022, 18:12
ATRA Atara Biotherapeutics, Inc. 16 Aug 2022 1 -$20,760 4 EVP, Head of R&D 18 Aug 2022, 18:21
/report/000120919123047246-dupont-jakob-2022-07-29-restatement Apexigen, Inc. 29 Jul 2022 0 $0 3/A Director 24 Aug 2023, 18:49
ATRA Atara Biotherapeutics, Inc. 17 May 2022 1 -$20,597 4 EVP, Head of R&D 19 May 2022, 17:08
ATRA Atara Biotherapeutics, Inc. 01 Mar 2022 3 -$21,890 4 EVP, Head of R&D 03 Mar 2022, 18:02
ATRA Atara Biotherapeutics, Inc. 10 Feb 2022 3 -$32,100 4 EVP, Head of R&D 14 Feb 2022, 16:42
ATRA Atara Biotherapeutics, Inc. 03 Jan 2022 3 -$32,150 4 EVP, Head of R&D 05 Jan 2022, 15:47
ATRA Atara Biotherapeutics, Inc. 01 Dec 2021 3 -$41,788 4 EVP, Head of R&D 03 Dec 2021, 15:15
ATRA Atara Biotherapeutics, Inc. 16 Nov 2021 1 -$37,640 4 EVP, Head of R&D 18 Nov 2021, 16:52
ATRA Atara Biotherapeutics, Inc. 02 Nov 2021 3 -$34,150 4 EVP, Head of R&D 04 Nov 2021, 16:10
ATRA Atara Biotherapeutics, Inc. 17 Aug 2021 1 -$26,969 4 EVP, Head of R&D 19 Aug 2021, 19:32
ATRA Atara Biotherapeutics, Inc. 18 May 2021 1 -$75,427 4 EVP, Head of R&D 20 May 2021, 16:32